Nasdaq granted separate conditional listing extensions on 29 Aug. to three small-capitalisation issuers struggling to meet the exchange’s US$1 minimum bid price rule. Movano Health received until 30 Sept. to file its delayed first- and second-quarter Form 10-Qs for 2025 and must lift its share price to at least US$1 by 30 Oct. to keep its spot on the Nasdaq Capital Market. Clinical-stage vaccine developer Vaxart was given a shorter window. The company must secure shareholder approval for a reverse stock split by 5 Sept., execute the split by 6 Oct. and show ten consecutive trading days above US$1 no later than 17 Oct., according to a decision letter from the Nasdaq Hearings Panel. Singapore-based Bit Origin, which operates in blockchain services, won an additional 180-day grace period, until 16 Feb. 2026, to push its ordinary shares back above the US$1 threshold. Failure to meet the requirement would trigger delisting proceedings, although the company could appeal.